These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2446137)

  • 1. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
    Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals.
    Winther MD; Allen G; Bomford RH; Brown F
    J Immunol; 1986 Mar; 136(5):1835-40. PubMed ID: 3005401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB; Ilyichev AA; Eroshkin AM; Karpenko LI; Pokrovsky AG; Pereboev AV; Svyatchenko VA; Ignat'ev GM; Smolina MI; Melamed NV; Lebedeva CD; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):129-37. PubMed ID: 8717396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacterial synthesis of immunogenic epitopes of foot-and-mouth disease virus fused either to human necrosis factor or to hepatitis B core antigen].
    Nekrasova OV; Boĭchenko VE; Boldyreva EF; Borisova GP; Pumpen P; Perevozchikova NA; Korobko VG
    Bioorg Khim; 1997 Feb; 23(2):118-26. PubMed ID: 9157845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
    Parry NR; Syred A; Rowlands DJ; Brown F
    Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
    Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
    Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren].
    Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R
    Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to uncoupled peptides of foot-and-mouth disease virus.
    Francis MJ; Fry CM; Rowlands DJ; Bittle JL; Houghten RA; Lerner RA; Brown F
    Immunology; 1987 May; 61(1):1-6. PubMed ID: 3034769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.
    Clarke BE; Brown AL; Grace KG; Hastings GZ; Brown F; Rowlands DJ; Francis MJ
    J Gen Virol; 1990 May; 71 ( Pt 5)():1109-17. PubMed ID: 1693163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria.
    Charbit A; Sobczak E; Michel ML; Molla A; Tiollais P; Hofnung M
    J Immunol; 1987 Sep; 139(5):1658-64. PubMed ID: 2442253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.